Stern Pinball Announces New James Bond 007 Pinball Machines
22.9.2022 17:00:00 EEST | Business Wire | Press release
Stern Pinball, Inc. launches a new line of pinball machines celebrating the iconic, genre-defining James Bond films. The James Bond 007 cornerstone series features the original 007 actor, Sean Connery, available in Pro Edition, Premium Edition, and Limited Edition (LE). Stern Pinball will also release a special James Bond 007 60th Anniversary Limited Edition pinball machine featuring all six James Bond actors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220922005077/en/
James Bond 007 Pinball Pro Edition (Photo: Business Wire)
In Dr. No (1962) Sean Connery propelled 007 into the cultural zeitgeist, bringing the legendary literary figure to life through adrenalized action sequences, ground-breaking gadgets and effects, memorable characters, and timeless villains.
Stern’s James Bond 007 cornerstone pinball machine will highlight film footage and iconic music from the films that built the 007 legend: Dr. No, From Russia With Love (1963), Goldfinger (1964), Thunderball (1965), You Only Live Twice (1967), and Diamonds Are Forever (1971). Players are immersed into the world of espionage in this action-packed pinball experience, tackling assignments, teaming up with key allies, and stopping SPECTRE’s villainous schemes.
Gather gadgets from Q Branch as pinballs get ejected through the roof of a custom sculpted Aston Martin DB5. Break through the Osato Chemicals drop targets to battle SPECTRE at the Bird 1 rocket base. And hold your breath on the gravity defying, magnetic jetpack as it transports pinballs across the playfield.
James Bond 007 pinball machines include Stern’s award-winning Insider Connected™ system, which enables players to interact with the game and a global network of players in a variety of ways. Through Insider Connected, players can track progress, earn new game-specific achievements, engage with the player community, and participate in promotions and Challenge Quests. Insider Connected also provides an operator-focused toolset to drive location play through Location Leaderboards, build player loyalty, analyze performance, make adjustments remotely, and maintain the machines. Registration for Insider Connected is available at insider.sternpinball.com/.
Limited to 1,000 machines globally, the highly collectible cornerstone Limited Edition includes an exclusive full-color mirrored backglass inspired by Thunderball, masterfully adapted cabinet artwork, custom high gloss and powder-coated pinball armor, a custom designer-autographed bottom arch, exclusive inside art blades, upgraded audio system, anti-reflection pinball playfield glass, shaker motor, a sequentially numbered plaque, and a Certificate of Authenticity signed by Stern Chairman Gary Stern and President Seth Davis.
Stern’s James Bond 007 60th Anniversary Limited Edition pinball machines will immerse players in the history of 007. Limited to 500 machines globally, the highly collectible 60th Anniversary Limited Edition offers players a retro-inspired playfield packed with exciting mechanical action. Control the chaos from Oddjob’s kinetic spinning disc hat, survive tactical precision shots against 10 drop targets, escape SPECTRE’s evil henchmen navigating pinballs through 4 fast-flowing optical spinners, learn assignments through an in-playfield LCD screen, and rack up high scores on classic-style score reels.
“James Bond is as timeless as pinball. Partnering with EON Productions/Danjaq, MGM Studios and Aston Martin, we created a pinball adventure capturing the suspense, action, and humor from this beloved film series,” said Gary Stern, Chairman and CEO. “Get connected today and become a legend.”
Fittingly, the new James Bond 007 pinball machines will be on show for the first time to media and public in London. On September 26th the games will be on display and available to play as part of the Bond-themed Christie’s Late, a public event celebrating the forthcoming Christie’s Sixty Years of James Bond Charity Auction. Shortly after, they will be a part of the James Bond at 60 weekend at the British Film Institute on the South Bank, September 30th-October 2nd.
Pricing and Availability:
Manufacturer’s Suggested Retail Price (“MSRP”)*:
*MSRP for sales to USA end-users, before any VAT, GST, Sales Tax, Duties, or other taxes.
Pro Edition: $US 6,999
Premium Edition: $US 9,699
Limited Edition: $US 12,999
60th Anniversary Limited Edition: CALL FOR PRICE
James Bond 007 pinball machines and accessories are available now through authorized Stern Pinball distributors and dealers around the world. Pro and Premium Editions will also be available at 007Store.com.
About Stern Pinball, Inc.
Stern Pinball, Inc. is a global lifestyle brand based on the iconic and outrageously fun modern American game of pinball. Headquartered minutes from Chicago’s O’Hare International Airport in the heart of North America, the company creates, designs, engineers, manufactures, markets, and distributes a full line of technologically advanced terrestrial and digital pinball games, parts, accessories, and merchandise. Stern Pinball serves digital, consumer, commercial, and corporate markets around the globe.
Recent Stern Pinball titles include Rush, Godzilla, The Mandalorian, Led Zeppelin, Avengers: Infinity Quest, Teenage Mutant Ninja Turtles, Stranger Things, Elvira’s House of Horrors, Jurassic Park, Black Knight: Sword of Rage, The Munsters, The Beatles, Deadpool, Iron Maiden, Guardians of the Galaxy, Star Wars, Aerosmith, Ghostbusters, KISS, Metallica, Game of Thrones, The Walking Dead, Star Trek, AC/DC, Batman, and Spider-Man. A broad range of players enjoy Stern Pinball’s games from professional pinball players who compete in high-stakes competitions around the globe to novice players who are discovering the allure of the silver ball for the first time. To join the fun and learn more, please visit www.sternpinball.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220922005077/en/
Contact information
Zach Sharpe
zach.sharpe@sternpinball.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom